Gocatamig: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
15
US states with sites
17
Countries
Phase breakdown
Phase 1 2
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Small Cell Lung Cancer | 1 |
| Small Cell Lung Cancer Extensive Stage | 1 |
Recruiting trials involving Gocatamig
- A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Common questions
How many recruiting trials involve Gocatamig?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.